ORIL is a public-unlisted biotech start-up headquartered in Adelaide, Australia;
Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach;
Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses
Based in Australia
Page created on Jun 20, 2018
Sydney Dance School for Children
Microsoft Dynamics Experts for Your Business Solution
Indian Wedding Photography in Sydney - RISS Productions
The One-stop Digital Agency For Website Design, Mobile Apps & Digital Marketing In Melbourne
We connect property seekers with trusted real estate agents and top property developers.
Quality affordable tyres & best prices
BEAMSTART is a hub for everything Startups, Entrepreneurship, and Innovation. Connect with a global community of people, and stay updated with the latest news, events, and opportunities.
Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities: